Oregon Public Employees Retirement Fund cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 56.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,779 shares of the company’s stock after selling 21,455 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Henry Schein were worth $1,219,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Fuller & Thaler Asset Management Inc. boosted its position in Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after buying an additional 800 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in Henry Schein by 1.8% in the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock valued at $3,399,000 after buying an additional 846 shares during the last quarter. BB&T Securities LLC boosted its position in Henry Schein by 26.8% in the 1st quarter. BB&T Securities LLC now owns 4,676 shares of the company’s stock valued at $314,000 after buying an additional 988 shares during the last quarter. Gabelli Funds LLC boosted its position in Henry Schein by 0.3% in the 1st quarter. Gabelli Funds LLC now owns 332,300 shares of the company’s stock valued at $22,334,000 after buying an additional 1,100 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its position in Henry Schein by 20.1% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,038 shares of the company’s stock valued at $511,000 after buying an additional 1,177 shares during the last quarter. Institutional investors and hedge funds own 96.65% of the company’s stock.

HSIC has been the topic of a number of recent research reports. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. Leerink Swann set a $100.00 price objective on Henry Schein and gave the company a “buy” rating in a research report on Tuesday, August 7th. BidaskClub raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, June 13th. Robert W. Baird increased their price target on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, August 7th. Finally, Craig Hallum increased their price target on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, August 7th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $84.11.

HSIC opened at $84.39 on Tuesday. Henry Schein, Inc. has a 1 year low of $62.56 and a 1 year high of $85.51. The stock has a market capitalization of $12.77 billion, a price-to-earnings ratio of 21.77, a PEG ratio of 2.40 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.68 and a current ratio of 1.29.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.03. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.31 billion. During the same quarter last year, the business posted $0.88 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. analysts expect that Henry Schein, Inc. will post 4.12 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: What is a Stop Order?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.